Charles Theuer - Feb 28, 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Stock symbol
TCON
Transactions as of
Feb 28, 2023
Transactions value $
$7,600
Form type
4
Date filed
3/2/2023, 05:24 AM
Previous filing
Feb 3, 2023
Next filing
Apr 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $304 +200 +0.06% $1.52 340K Feb 28, 2023 Direct
transaction TCON Common Stock Purchase $7.3K +4.8K +1.41% $1.52 345K Mar 1, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.